Israeli technology startup Zebra Medical Vision claims it is the first such company to receive U.S. FDA clearance for an artificial intelligence solution across three different modalities.
The latest comes for its HealthMammo algorithm, which helps radiologists pinpoint and prioritize suspicious breast images. Zebra said Monday that the software, already cleared in Europe, can act as a “safety net” for busy physicians playing catchup during the pandemic.
“Our work is twofold: supporting the medical team’s overload and ensuring the well-being of patients, by supporting early detection and reducing the anxiety surrounding uncertainty,” Zebra CEO Ohad Arazi said in a statement issued July 27.
The Shefayim, Israel-based company said this is its first solution in oncology and sixth overall clearance. Previous approvals also included solutions in computed tomography and x-ray imaging, according to the announcement.